ClinicalTrials.Veeva

Menu

Clinical and Laboratory Profile of Myasthenia Gravis in Children At Sohag University Hospitals

S

Sohag University

Status

Not yet enrolling

Conditions

Myasthenia Gravis in Children

Treatments

Diagnostic Test: All patients in this study were subjected to the followings: (A) Clinical history focusing on: Sociodemographic data: age, gender , residence,and degree of consanguinity. Full neurodevelopmental his
Diagnostic Test: EMG ,rNST,Ach R antibodies & thyroid function

Study type

Observational

Funder types

Other

Identifiers

NCT06774937
Soh-Med-24-09-03MS

Details and patient eligibility

About

This study includes clinical and laboratory studies of patients with Myathenia gravis at Sohag Neurology outpatient clinic of pediatric department

Full description

All patients in this study were subjected to the followings:

(A) Clinical history focusing on: Sociodemographic data: age, gender , residence,and degree of consanguinity. Full neurodevelopmental history: neurological evaluation Family history. Mode of delivery

(B) Thorough clinical examination: General examination including general look, vital signs and anthropometric measurements.

Scale system include gross motor function and muscle power(Quantitative Myasthenia Gravis Scale) [36] detailed neurological examination including motor ,sensory and reflexes. (C) Investigations:

  1. Electrophysiological testing:

    EMG : is especially useful in diagnosis of seronegative MG and congenital myasthenic syndromes.

    NCS: including repetitive nerve stimulation test (r NST)

  2. laboratory studies: Serology. Detection of antibodies to the AChR supports the diagnosis of JMG. In young children where AChR antibodies are negative this can lead to difficulty in differentiating from CMS.

    Thyroid function tests :

  3. Imaging:

    CT chest: Although thymoma in children is rare, the thymus must be imaged once JMG has been diagnosed.

  4. molecular studies (when possible).

Enrollment

20 estimated patients

Sex

All

Ages

1 month to 16 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • All patients from 1 month to 16 years confirmed diagnosis of myasthenia gravis by neurological and laboratory data.

Care giver accept to participate in the study.

Exclusion criteria

  • Failure to obtain informed consent. Other neurological and neuromuscular disorders. Age above 16 years.

Trial design

20 participants in 1 patient group

One group of patients againg one month to 16 years old with myasthenia gravis
Description:
Patients diagnosed with myasthenia gravis at the pediatric out patient clinic by clinical charactristics ,nerve study and laboratory data will be elligable for the study. Inclusion Criteria: * All patients from 1 month to 16 years confirmed diagnosis of myasthenia gravis by neurological and laboratory data. * Care giver accept to participate in the study.
Treatment:
Diagnostic Test: EMG ,rNST,Ach R antibodies & thyroid function
Diagnostic Test: All patients in this study were subjected to the followings: (A) Clinical history focusing on: Sociodemographic data: age, gender , residence,and degree of consanguinity. Full neurodevelopmental his

Trial contacts and locations

2

Loading...

Central trial contact

Menna Mohamed

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems